author-photo

Andrew Feifer

HealthPartners

2

Papers

5

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

2020 Cuaj-canadian Urological Association Journal
Show All
- Source
- Cite
- Save
Citations (2)
Real-world evidence in patient-related outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate plus prednisone (AA+P).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)